NDC properties for "ampicillin (as ampicillin sodium) 2 GM / sulbactam (as sulbactam sodium) 1 GM Injection" (RxCUI 1659598)
About this data
The tables show NDC propoerties for ampicillin (as ampicillin sodium) 2 GM / sulbactam (as sulbactam sodium) 1 GM Injection with the RxCUI 1659598
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for ampicillin (as ampicillin sodium) 2 GM / sulbactam (as sulbactam sodium) 1 GM Injection (RxCUI 1659598)
ANDA | ANDA065176 |
---|---|
ANDA | ANDA065222 |
ANDA | ANDA065310 |
ANDA | ANDA065406 |
ANDA | ANDA090340 |
ANDA | ANDA090349 |
ANDA | ANDA090579 |
ANDA | ANDA201024 |
ANDA | ANDA201406 |
MMSL_CODE | BD1346 |
MMSL_CODE | CD1346 |
RxCUI | 1659598 |
SNOMEDCT | 370419006 |
SPL_SET_ID | 006f9a3f-b4e3-4aa5-ac65-6cc3d3e2582d |
SPL_SET_ID | 16fdfdb9-9e26-48d0-8838-570d30c8e897 |
SPL_SET_ID | 1e5004f1-e79e-4e0b-9f3f-25f6bbc15255 |
SPL_SET_ID | 6ae2c4a1-f704-4642-bbdd-f69a9ef07605 |
SPL_SET_ID | 7161f386-6373-4db5-8dfd-d7ddf38ec2f1 |
SPL_SET_ID | 71b45af0-7363-4c93-8106-0a2220e62d9e |
SPL_SET_ID | 72a37674-8cb2-4b40-aac8-d345ffcf22f2 |
SPL_SET_ID | 942ea2a7-8a1b-405e-a802-2ff0debc388b |
SPL_SET_ID | 9a722de6-9dc0-4fb9-b63a-225385aa3314 |
SPL_SET_ID | a67ae347-487d-4751-a841-b321e81db26f |
SPL_SET_ID | ac6f8158-9d7e-4b99-af3c-0407c5287b57 |
SPL_SET_ID | adc92303-b62b-41c8-becf-9c3a4e8c3a6b |
SPL_SET_ID | bb78b01f-b235-4a3e-b3d2-24543d3fd56c |
SPL_SET_ID | d3026cc0-95d8-44cf-be47-b5ebb8fd4568 |
SPL_SET_ID | d4e9ca30-7af3-42ec-e053-2995a90afe1f |
SPL_SET_ID | dc374fa4-350b-425d-a7db-7099fdc64cf1 |
SPL_SET_ID | e6cf14a8-3ed9-4a7a-ba69-be0b794cbdc4 |
SPL_SET_ID | f8e534d8-5bb8-47c4-a11e-ec67f0609d1d |
VUID | 4008599 |
Prescribable Synonym | ampicillin / sulbactam 3 GM Injection |
RXNAV_STR | ampicillin 2000 MG / sulbactam 1000 MG Injection |
RxNorm Name | ampicillin 2000 MG / sulbactam 1000 MG Injection |
RxNorm Synonym | ampicillin (as ampicillin sodium) 2 GM / sulbactam (as sulbactam sodium) 1 GM Injection |
RxNorm Synonym | ampicillin 2 GM / sulbactam 1 GM Injection |
Related queries | Interactions (for RxCUI 1659598) |
NDC Properties
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 00409298703
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-03 |
NDC Item | 00409298703 |
Packaging | 10 VIAL in 1 TRAY (0409-2987-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2987-23) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298723
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-23 |
NDC Item | 00409298723 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00409298749
NDC 9 | 0409-2987 |
---|---|
NDC 10 | 0409-2987-49 |
NDC Item | 00409298749 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2987 |
NDC Item 00641611701
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-01 |
NDC Item | 00641611701 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641611710
NDC 9 | 0641-6117 |
---|---|
NDC 10 | 0641-6117-10 |
NDC Item | 00641611710 |
Packaging | 10 VIAL in 1 CARTON (0641-6117-10) / 3 g in 1 VIAL (0641-6117-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6117 |
NDC Item 00641612001
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-01 |
NDC Item | 00641612001 |
Packaging | 3 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612010
NDC 9 | 0641-6120 |
---|---|
NDC 10 | 0641-6120-10 |
NDC Item | 00641612010 |
Packaging | 10 VIAL in 1 CARTON (0641-6120-10) / 3 g in 1 VIAL (0641-6120-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6120 |
NDC Item 00641612301
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-01 |
NDC Item | 00641612301 |
Packaging | 8 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00641612310
NDC 9 | 0641-6123 |
---|---|
NDC 10 | 0641-6123-10 |
NDC Item | 00641612310 |
Packaging | 10 VIAL in 1 CARTON (0641-6123-10) / 8 mL in 1 VIAL (0641-6123-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6123 |
NDC Item 00781303370
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-70 |
NDC Item | 00781303370 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 00781303395
NDC 9 | 0781-3033 |
---|---|
NDC 10 | 0781-3033-95 |
NDC Item | 00781303395 |
Packaging | 10 VIAL in 1 CARTON (0781-3033-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3033-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3033 |
NDC Item 25021014330
NDC 9 | 25021-143 |
---|---|
NDC 10 | 25021-143-30 |
NDC Item | 25021014330 |
Packaging | 10 VIAL in 1 CARTON (25021-143-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-143 |
NDC Item 25021018730
NDC 9 | 25021-187 |
---|---|
NDC 10 | 25021-187-30 |
NDC Item | 25021018730 |
Packaging | 10 VIAL in 1 CARTON (25021-187-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-187 |
NDC Item 44567015010
NDC 9 | 44567-150 |
---|---|
NDC 10 | 44567-150-10 |
NDC Item | 44567015010 |
Packaging | 10 VIAL in 1 CARTON (44567-150-10) / 20 mL in 1 VIAL |
ANDA | ANDA201406 |
FDA SPL set id | 805335 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-150 |
NDC Item 44567021110
NDC 9 | 44567-211 |
---|---|
NDC 10 | 44567-211-10 |
NDC Item | 44567021110 |
Packaging | 10 VIAL in 1 CARTON (44567-211-10) / 20 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-211 |
NDC Item 55150011701
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-01 |
NDC Item | 55150011701 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011710
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-10 |
NDC Item | 55150011710 |
Packaging | 10 VIAL in 1 CARTON (55150-117-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150011720
NDC 9 | 55150-117 |
---|---|
NDC 10 | 55150-117-20 |
NDC Item | 55150011720 |
Packaging | 10 VIAL in 1 CARTON (55150-117-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
FDA SPL set id | 826516 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-117 |
NDC Item 55150017999
NDC 9 | 55150-179 |
---|---|
NDC 10 | 55150-179-99 |
NDC Item | 55150017999 |
Packaging | 10 BOTTLE in 1 BOX (55150-179-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-179 |
NDC Item 63323036920
NDC 9 | 63323-369 |
---|---|
NDC 10 | 63323-369-20 |
NDC Item | 63323036920 |
Packaging | 10 VIAL in 1 CARTON (63323-369-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-369 |
NDC Item 66794020702
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-02 |
NDC Item | 66794020702 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794020741
NDC 9 | 66794-207 |
---|---|
NDC 10 | 66794-207-41 |
NDC Item | 66794020741 |
Packaging | 10 VIAL in 1 CARTON (66794-207-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-207-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-207 |
NDC Item 66794024202
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-02 |
NDC Item | 66794024202 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 66794024241
NDC 9 | 66794-242 |
---|---|
NDC 10 | 66794-242-41 |
NDC Item | 66794024241 |
Packaging | 10 VIAL in 1 CARTON (66794-242-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-242-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-242 |
NDC Item 67457022600
NDC 9 | 67457-226 |
---|---|
NDC 10 | 67457-226-00 |
NDC Item | 67457022600 |
ANDA | ANDA065316 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2014-05-31 |
Marketing effective time low | 2012-11-27 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-226 |
NDC Item 67457034903
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-03 |
NDC Item | 67457034903 |
Packaging | 1 VIAL in 1 CARTON (67457-349-03) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67457034910
NDC 9 | 67457-349 |
---|---|
NDC 10 | 67457-349-10 |
NDC Item | 67457034910 |
Packaging | 10 VIAL in 1 CARTON (67457-349-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 675125 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-02-29 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-349 |
NDC Item 67850013100
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-00 |
NDC Item | 67850013100 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 67850013110
NDC 9 | 67850-131 |
---|---|
NDC 10 | 67850-131-10 |
NDC Item | 67850013110 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-131-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-131-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-131 |
NDC Item 70594008201
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-01 |
NDC Item | 70594008201 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 70594008202
NDC 9 | 70594-082 |
---|---|
NDC 10 | 70594-082-02 |
NDC Item | 70594008202 |
Packaging | 10 VIAL in 1 CARTON (70594-082-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-082-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-082 |
NDC Item 71288000630
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-30 |
NDC Item | 71288000630 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-006-30) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-006-31) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288000631
NDC 9 | 71288-006 |
---|---|
NDC 10 | 71288-006-31 |
NDC Item | 71288000631 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-11-30 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-006 |
NDC Item 71288003220
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-20 |
NDC Item | 71288003220 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003221
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-21 |
NDC Item | 71288003221 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003291
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-91 |
NDC Item | 71288003291 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 71288003292
NDC 9 | 71288-032 |
---|---|
NDC 10 | 71288-032-92 |
NDC Item | 71288003292 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-032-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-032-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-032 |
NDC Item 72485041701
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-01 |
NDC Item | 72485041701 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72485041710
NDC 9 | 72485-417 |
---|---|
NDC 10 | 72485-417-10 |
NDC Item | 72485041710 |
Packaging | 10 VIAL in 1 CARTON (72485-417-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-417-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 824330 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-417 |
NDC Item 72572002201
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-01 |
NDC Item | 72572002201 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72572002210
NDC 9 | 72572-022 |
---|---|
NDC 10 | 72572-022-10 |
NDC Item | 72572002210 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-022-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-022-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-022 |
NDC Item 72603033501
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-01 |
NDC Item | 72603033501 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 72603033510
NDC 9 | 72603-335 |
---|---|
NDC 10 | 72603-335-10 |
NDC Item | 72603033510 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-335-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-335-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-335 |
NDC Item 82449051401
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-01 |
NDC Item | 82449051401 |
Packaging | 1 VIAL in 1 CARTON (82449-514-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |
NDC Item 82449051402
NDC 9 | 82449-514 |
---|---|
NDC 10 | 82449-514-02 |
NDC Item | 82449051402 |
Packaging | 10 VIAL in 1 CARTON (82449-514-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 824409 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-514 |